Fei Xiao
- Molecular Biology top 10%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Oncology
- Epidemiology
- Co-authors
- Lihui ZouKathleen M. McAndrewsAntonios ChronopoulosFernanda G. KugeratskiValerie S. LeBleuRaghu KalluriJunhua JinDeruo Liu
- Topics
- Lung Cancer Diagnosis and Treatment (16 papers)RNA modifications and cancer (10 papers)Circular RNAs in diseases (9 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyNucleic Acids Research
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fei Xiao
119 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 135
- Molecular Biology 898
- Cancer Research 493
- Pulmonary and Respiratory Medicine 338
- Oncology 189
- Epidemiology 157
Countries citing papers authored by Fei Xiao
This map shows the geographic impact of Fei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Xiao more than expected).
Fields of papers citing papers by Fei Xiao
This network shows the impact of papers produced by Fei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Xiao. The network helps show where Fei Xiao may publish in the future.
Co-authorship network of co-authors of Fei Xiao
This figure shows the co-authorship network connecting the top 25 collaborators of Fei Xiao. A scholar is included among the top collaborators of Fei Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Xiao. Fei Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 7 | |
| 9 | 19 | |
| 10 | 22 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | 12 | |
| 14 | 12 | |
| 15 | 12 | |
| 16 | 21 | |
| 17 | 25 | |
| 18 | miR-139 Controls Viability Of Ovarian Cancer Cells Through Apoptosis Induction And Exosome Shedding Inhibition By Targeting ATP7A | 0 |
| 19 | 24 | |
| 20 | 19 |
About Fei Xiao
Fei Xiao is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 126 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (16 papers), RNA modifications and cancer (10 papers) and Circular RNAs in diseases (9 papers). The work is most often cited by research in Cancer Research (493 citations), Molecular Biology (898 citations) and Pulmonary and Respiratory Medicine (338 citations). Fei Xiao has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lihui Zou, Kathleen M. McAndrews, Antonios Chronopoulos, Fernanda G. Kugeratski, Valerie S. LeBleu, Raghu Kalluri, Junhua Jin, Deruo Liu, Qi Pan and Yanming Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.